About
Andrei Pikalov, MD, PhD, is affiliated with Sunovion Pharmaceuticals Inc. in Teaneck, New Jersey, and Marlborough, Massachusetts. Since 2007, Pikalov has published extensively on the treatment of psychiatric conditions including major depressive disorder, bipolar disorder, schizophrenia, and schizoaffective disorders. His work has focused on the clinical effects and safety of antipsychotic medications such as lurasidone and aripiprazole, addressing topics like anxiety symptoms, sexual dysfunction, metabolic syndrome, and movement disorders. Pikalov's research also encompasses neurology and sleep-related issues within these clinical populations.
